BACKGROUND: The instantaneous rate of change of alcohol exposure (slope) may contribute to changes in measures of brain function following administration of alcohol that are usually attributed to breath alcohol concentration (BrAC) acting alone. To test this proposition, a 2-session experiment was designed in which carefully prescribed, constant-slope trajectories of BrAC intersected at the same exposure level and time since the exposure began. This paper presents the methods and limitations of the experimental design. METHODS: Individualized intravenous infusion rate profiles of 6% ethanol (EtOH) that achieved the constant-slope trajectories for an individual were precomputed using a physiologically based pharmacokinetic model. Adjusting the parameters of the model allowed each infusion profile to account for the subject's EtOH distribution and elimination kinetics. Sessions were conducted in randomized order and made no use of feedback of BrAC measurements obtained during the session to modify the precalculated infusion profiles. In one session, an individual's time course of exposure, BrAC(t), was prescribed to rise at a constant rate of 6.0 mg% per minute until it reached 68 mg% and then descend at -1.0 mg% per minute; in the other, to rise at a rate of 3.0 mg% per minute. The 2 exposure trajectories were designed to intersect at a BrAC (t = 20 minutes) = 60 mg% at an experimental time of 20 minutes. RESULTS: Intersection points for 54 of 61 subjects were within prescribed deviations (range of ± 3 mg% and ± 4 minutes from the nominal intersection point). CONCLUSIONS: Results confirmed the feasibility of applying the novel methods for achieving the intended time courses of the BrAC, with technical problems limiting success to 90% of the individuals tested.
RCT Entities:
BACKGROUND: The instantaneous rate of change of alcohol exposure (slope) may contribute to changes in measures of brain function following administration of alcohol that are usually attributed to breath alcohol concentration (BrAC) acting alone. To test this proposition, a 2-session experiment was designed in which carefully prescribed, constant-slope trajectories of BrAC intersected at the same exposure level and time since the exposure began. This paper presents the methods and limitations of the experimental design. METHODS: Individualized intravenous infusion rate profiles of 6% ethanol (EtOH) that achieved the constant-slope trajectories for an individual were precomputed using a physiologically based pharmacokinetic model. Adjusting the parameters of the model allowed each infusion profile to account for the subject's EtOH distribution and elimination kinetics. Sessions were conducted in randomized order and made no use of feedback of BrAC measurements obtained during the session to modify the precalculated infusion profiles. In one session, an individual's time course of exposure, BrAC(t), was prescribed to rise at a constant rate of 6.0 mg% per minute until it reached 68 mg% and then descend at -1.0 mg% per minute; in the other, to rise at a rate of 3.0 mg% per minute. The 2 exposure trajectories were designed to intersect at a BrAC (t = 20 minutes) = 60 mg% at an experimental time of 20 minutes. RESULTS: Intersection points for 54 of 61 subjects were within prescribed deviations (range of ± 3 mg% and ± 4 minutes from the nominal intersection point). CONCLUSIONS: Results confirmed the feasibility of applying the novel methods for achieving the intended time courses of the BrAC, with technical problems limiting success to 90% of the individuals tested.
Authors: Rosane Gomez; Kevin L Behar; June Watzl; Stuart A Weinzimer; Barbara Gulanski; Gerard Sanacora; Julia Koretski; Elizabeth Guidone; Lihong Jiang; Ismene L Petrakis; Brian Pittman; John H Krystal; Graeme F Mason Journal: Biol Psychiatry Date: 2011-08-19 Impact factor: 13.382
Authors: Martin H Plawecki; Jae-Joon Han; Peter C Doerschuk; Vijay A Ramchandani; Sean J O'Connor Journal: IEEE Trans Biomed Eng Date: 2008-12 Impact factor: 4.538
Authors: Joshua L Gowin; Matthew E Sloan; Bethany L Stangl; Vatsalya Vatsalya; Vijay A Ramchandani Journal: Am J Psychiatry Date: 2017-08-04 Impact factor: 18.112
Authors: Nicole M Strang; Eric D Claus; Vijay A Ramchandani; Ariel Graff-Guerrero; Isabelle Boileau; Christian S Hendershot Journal: Psychopharmacology (Berl) Date: 2014-08-12 Impact factor: 4.530
Authors: M E Sloan; T D Klepp; J L Gowin; J E Swan; H Sun; B L Stangl; V A Ramchandani Journal: Neuropsychopharmacology Date: 2018-02-02 Impact factor: 7.853
Authors: Martin Henry Plawecki; Adnan Mahmood Durrani; Julian Boes; Leah Wetherill; Ann Kosobud; Sean O'Connor; Vijay A Ramchandani Journal: Alcohol Clin Exp Res Date: 2019-02-28 Impact factor: 3.455
Authors: Elisabeth Jünger; Gabriela Gan; Inge Mick; Christian Seipt; Alexandra Markovic; Christian Sommer; Martin H Plawecki; Sean O'Connor; Michael N Smolka; Ulrich S Zimmermann Journal: Alcohol Clin Exp Res Date: 2016-06-24 Impact factor: 3.455
Authors: Martin Henry Plawecki; Kurt White; Ann E K Kosobud; Nicholas Grahame; Ulrich S Zimmermann; David Crabb; Sean O'Connor Journal: Alcohol Clin Exp Res Date: 2018-08-29 Impact factor: 3.455
Authors: Elisabeth Obst; Nadine Bernhardt; Gabriela Gan; Martin H Plawecki; Sean O'Connor; Michael N Smolka; Ulrich S Zimmermann Journal: Psychol Addict Behav Date: 2020-06-25